ANI Pharmaceuticals, Inc. (ANIP)

Market Cap	1.04B
Revenue (ttm)	555.46M
Net Income (ttm)	-8.77M
Shares Out	19.52M
EPS (ttm)	-0.46
PE Ratio	n/a
Forward PE	10.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	947,872
Open	53.69
Previous Close	54.26
Day's Range	53.01 - 54.56
52-Week Range	52.00 - 70.81
Beta	0.73
Analysts	Buy
Price Target	77.33 (+44.95%)
Earnings Date	Nov 8, 2024

About ANIP

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmac...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 642
• Stock Exchange: NASDAQ
• Ticker Symbol: ANIP
• Website: https://www.anipharmaceuticals.com

Analyst Forecast

According to 7 analysts, the average rating for ANIP stock is "Buy." The 12-month stock price forecast is $77.33, which is an increase of 44.95% from the latest price.

Price Target

$77.33

(44.95% upside)

Analyst Consensus: Buy